2014. ISPOR Annual International Meeting – Sustained Improvements in Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus Following Epratuzumab Treatment: Results from a Phase IIB Study and its Open-Label Extension

Strand V, Merrill J, Nikai E, Kilgallen B, Regnault A, Gordon C. Sustained Improvements in Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus Following Epratuzumab Treatment: Results from a Phase IIB Study and its Open-Label Extension. Value Health. 2014 May;17(3):A232-A233. Presented at: ISPOR 19th Annual International Meeting; June 3, 2014; Montreal, Canada.